159 related articles for article (PubMed ID: 32691644)
1. Pilocytic Astrocytoma: A Review of General, Clinical, and Molecular Characteristics.
Salles D; Laviola G; Malinverni ACM; Stávale JN
J Child Neurol; 2020 Oct; 35(12):852-858. PubMed ID: 32691644
[TBL] [Abstract][Full Text] [Related]
2. Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas.
Appay R; Fina F; Macagno N; Padovani L; Colin C; Barets D; Ordioni J; Scavarda D; Giangaspero F; Badiali M; Korshunov A; M Pfister S; T W Jones D; Figarella-Branger D
Mod Pathol; 2018 Oct; 31(10):1490-1501. PubMed ID: 29802359
[TBL] [Abstract][Full Text] [Related]
3. The involvement of the MAPK pathway in pilocytic astrocytomas.
Salles D; Santino SF; Ribeiro DA; Malinverni ACM; Stávale JN
Pathol Res Pract; 2022 Apr; 232():153821. PubMed ID: 35231859
[TBL] [Abstract][Full Text] [Related]
4. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
5. BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults.
Hasselblatt M; Riesmeier B; Lechtape B; Brentrup A; Stummer W; Albert FK; Sepehrnia A; Ebel H; Gerss J; Paulus W
Neuropathol Appl Neurobiol; 2011 Dec; 37(7):803-6. PubMed ID: 21696415
[TBL] [Abstract][Full Text] [Related]
6. BRAF Fusion Analysis in Pilocytic Astrocytomas: KIAA1549-BRAF 15-9 Fusions Are More Frequent in the Midline Than Within the Cerebellum.
Faulkner C; Ellis HP; Shaw A; Penman C; Palmer A; Wragg C; Greenslade M; Haynes HR; Williams H; Lowis S; White P; Williams M; Capper D; Kurian KM
J Neuropathol Exp Neurol; 2015 Sep; 74(9):867-72. PubMed ID: 26222501
[TBL] [Abstract][Full Text] [Related]
7. Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.
Tian Y; Rich BE; Vena N; Craig JM; Macconaill LE; Rajaram V; Goldman S; Taha H; Mahmoud M; Ozek M; Sav A; Longtine JA; Lindeman NI; Garraway LA; Ligon AH; Stiles CD; Santagata S; Chan JA; Kieran MW; Ligon KL
J Mol Diagn; 2011 Nov; 13(6):669-77. PubMed ID: 21884820
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of disseminated pilocytic astrocytomas.
Gessi M; Engels AC; Lambert S; Rothämel T; von Hornstein S; Collins VP; Denkhaus D; Gnekow A; Pietsch T
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):273-8. PubMed ID: 26084390
[TBL] [Abstract][Full Text] [Related]
9. Pilocytic astrocytoma: a disease with evolving molecular heterogeneity.
Sadighi Z; Slopis J
J Child Neurol; 2013 May; 28(5):625-32. PubMed ID: 23439714
[TBL] [Abstract][Full Text] [Related]
10. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological Study of Pilomyxoid-Spectrum Astrocytomas:An Analysis of the BRAF Gene. Report of Two Cases].
Ito T; Sato K; Oikawa M; Sugio H; Asanome T; Ozaki Y; Nakamura H; Tanaka S; Tsuda M; Nagashima K
No Shinkei Geka; 2015 Sep; 43(9):825-33. PubMed ID: 26321697
[TBL] [Abstract][Full Text] [Related]
12. Adult pilocytic astrocytomas: clinical features and molecular analysis.
Theeler BJ; Ellezam B; Sadighi ZS; Mehta V; Tran MD; Adesina AM; Bruner JM; Puduvalli VK
Neuro Oncol; 2014 Jun; 16(6):841-7. PubMed ID: 24470550
[TBL] [Abstract][Full Text] [Related]
13. Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss.
Kim YH; Nonoguchi N; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Mariani L; Giangaspero F; Tanaka Y; Nakazato Y; Vital A; Mittelbronn M; Perry A; Ohgaki H
Brain Pathol; 2012 Nov; 22(6):834-40. PubMed ID: 22568401
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological evaluation of pilocytic astrocytoma in adults: Histopathological and immunohistochemical analysis.
Santino SF; Salles D; Stávale JN; Malinverni ACM
Pathol Res Pract; 2023 Aug; 248():154593. PubMed ID: 37331182
[TBL] [Abstract][Full Text] [Related]
15. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas; a novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential.
Jeuken JW; Wesseling P
J Pathol; 2010 Dec; 222(4):324-8. PubMed ID: 20976706
[TBL] [Abstract][Full Text] [Related]
16. "Integrated diagnosis" of pilocytic astrocytoma: Molecular diagnostic procedure for an unusual case.
Ishida Y; Tsuda M; Sawamura Y; Fujii K; Murai H; Horiuchi N; Orba Y; Sawa H; Hall WW; Nagashima K; Tanaka S
Pathol Int; 2018 Dec; 68(12):694-699. PubMed ID: 30417961
[TBL] [Abstract][Full Text] [Related]
17. Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups.
Kurani H; Gurav M; Shetty O; Chinnaswamy G; Moiyadi A; Gupta T; Jalali R; Epari S
Childs Nerv Syst; 2019 Sep; 35(9):1525-1536. PubMed ID: 31321520
[TBL] [Abstract][Full Text] [Related]
18. Pilocytic astrocytoma in adults: Histopathological, immunohistochemical and molecular study with clinical association.
Salles D; Santino SF; Diana P; Malinverni ACM; Stávale JN
Pathol Res Pract; 2023 Dec; 252():154942. PubMed ID: 37984046
[TBL] [Abstract][Full Text] [Related]
19. Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.
Roth JJ; Fierst TM; Waanders AJ; Yimei L; Biegel JA; Santi M
J Neuropathol Exp Neurol; 2016 Apr; 75(4):306-15. PubMed ID: 26945035
[TBL] [Abstract][Full Text] [Related]
20. Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.
Selt F; Hohloch J; Hielscher T; Sahm F; Capper D; Korshunov A; Usta D; Brabetz S; Ridinger J; Ecker J; Oehme I; Gronych J; Marquardt V; Pauck D; Bächli H; Stiles CD; von Deimling A; Remke M; Schuhmann MU; Pfister SM; Brummer T; Jones DT; Witt O; Milde T
Oncotarget; 2017 Feb; 8(7):11460-11479. PubMed ID: 28002790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
